Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-02

FDA Approved: PRIMAQUINE PHOSPHATE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for Primaquine Phosphate from Sanofi-Aventis U.S. LLC, leading to a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMAQUINE PHOSPHATE (primaquine phosphate)

Snippet

SUPPL AP for PRIMAQUINE PHOSPHATE (PRIMAQUINE PHOSPHATE)